Abstract
The purpose of this study was to examine trends in incidence and detection of ductal carcinoma in situ (DCIS) of the breast in southern Netherlands in the period 1984–2006 and assess the effect of mass screening. All patients with primary DCIS registered between 1984 and 2006 in the population-based Eindhoven Cancer Registry were included (n = 1,767). These data were linked to data from the population-based screening programme. The incidence of DCIS of the breast increased from 3/100,000 to almost 34/100,000 person-years in women aged 50–69 years in southern Netherlands since 1984. Mass screening was responsible for this increase. A stable 60% of DCIS was screen-detected. Over 11% of breast cancer patients have DCIS. In conclusion, the incidence of DCIS increased markedly in southern Netherlands with a clear effect of mammography screening since 1992.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Louwman WJ, Voogd AC, van Dijck JA et al (2008) On the rising trends of incidence and prognosis for breast cancer patients diagnosed 1975–2004: a long-term population-based study in southeastern Netherlands. Cancer Causes Control 19(1):97–106. doi:10.1007/s10552-007-9075-8
Welch HG, Black WC (1997) Using autopsy series to estimate the disease “reservoir” for ductal carcinoma in situ of the breast: how much more breast cancer can we find? Ann Intern Med 127(11):1023–1028
Ernster VL, Ballard-Barbash R, Barlow WE et al (2002) Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 94(20):1546–1554
Barchielli A, Federico M, De Lisi V et al (2005) In situ breast cancer: incidence trend and organised screening programmes in Italy. Eur J Cancer 41(7):1045–1050
Fracheboud J, Otto SJ, van Dijck JA et al (2004) Decreased rates of advanced breast cancer due to mammography screening in The Netherlands. Br J Cancer 91(5):861–867
Stichting Bevolkingsonderzoek Borstkanker Zuid (2006) Jaarverslag 2006 Stichting Bevolkingsonderzoek Borstkanker Zuid
Otten JD, Karssemeijer N, Hendriks JH et al (2005) Effect of recall rate on earlier screen detection of breast cancers based on the Dutch performance indicators. J Natl Cancer Inst 97(10):748–754
Brekelmans CT, Seynaeve C, Bartels CC et al (2001) Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. J Clin Oncol 19(4):924–930
Ernster VL, Barclay J, Kerlikowske K et al (1996) Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 275(12):913–918. doi:10.1001/jama.275.12.913
Levi F, Te VC, Randimbison L et al (1997) Trends of in situ carcinoma of the breast in Vaud, Switzerland. Eur J Cancer 33(6):903–906. doi:10.1016/S0959-8049(97) 00048-8
Zheng T, Holford TR, Chen Y et al (1997) Time trend of female breast carcinoma in situ by race and histology in Connecticut, USA. Eur J Cancer 33(1):96–100. doi:10.1016/S0959-8049(96) 00371-1
Choi WS, Parker BA, Pierce JP et al (1996) Regional differences in the incidence and treatment of carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev 5(4):317–320
Soerjomataram I, Coebergh JW, Louwman MW et al (2007) Does the decrease in hormone replacement therapy also affect breast cancer risk in the Netherlands? J Clin Oncol 25(31):5038–5039. doi:10.1200/JCO.2007.13.7281 (author reply 5039–5040)
Acknowledgement
The authors thank the registration team of the Eindhoven Cancer Registry for their dedicated data collection.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
van Steenbergen, L.N., Voogd, A.C., Roukema, J.A. et al. Screening caused rising incidence rates of ductal carcinoma in situ of the breast. Breast Cancer Res Treat 115, 181–183 (2009). https://doi.org/10.1007/s10549-008-0067-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-008-0067-5